Ryan Pollack's  Instablog

Ryan Pollack
Send Message
Ryan is an individual investor with an MBA in Investment Management at the Lubin School of Business at Pace University in New York City.
  • GE+Geron 0 comments
    Jun 30, 2009 7:35 PM | about stocks: GERN

    Nice surprise today with a GE-Geron business deal. This could revolutionize how clinical trials are done; testing drugs on human cells instead of animals. This could potentially save billions a year for pharma/biotech in clinical trial costs and thus reducing the expense of drugs for you and I. Not a surprise to see Feuerstein bashing as he does all biotechs. Can't blame the puppet when the master pulls the strings though. He is of no importance to the ultimate performance of the stock.

    Disclosure: Long GERN

    Stocks: GERN
Back To Ryan Pollack's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • We have an earnings calendar. Can we get a dividend calendar as well? $SPY
    Jun 4, 2016
  • I don't see how or why $T would be interested in or able to buy $YHOO core business after all of their recent purchases. Let $VZ get it
    Feb 22, 2016
  • Good divvy growth in 2016 so far. $ADM 7%, $ALL 10% and $CSCO 24%
    Feb 12, 2016
More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.